April 2023 in “Journal of Investigative Dermatology”
ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hairloss, with increased hair density and less side effects.
A 20-year-old is experiencing hair thinning and is considering Clascoterone and Minoxidil as treatments, avoiding finasteride due to concerns about fertility and hormones. A suggestion was made to use Clascoterone for local DHT targeting and combine it with Minoxidil for maintenance and regrowth while avoiding systemic side effects.
A 27-year-old male experiencing hairloss post-Covid is considering PRP (platelet-rich plasma) therapy. He's seeking personal experiences about the process, particularly regarding pain levels, despite his dermatologist's assurance of using local anesthesia.
An 18-year-old in India is seeking a dutasteride prescription for aggressive hairloss, as family members are bald by age 20. Local doctors advised against it, so they are considering using Indian telemedicine apps for a prescription.
The user experienced hairloss and initially saw improvement with Finasteride but is now considering switching to Dutasteride due to lack of recent results. They plan to add topical Minoxidil and are awaiting biopsy results to determine the cause of hairloss.
Pyrilutamide powder is now available at a local supermarket in the Netherlands. The discussion humorously touches on hairloss treatments like Minoxidil, finasteride, and RU58841.